Suppr超能文献

以心脏横纹肌瘤为首发症状的结节性硬化症产前诊断的多学科方法

A Multidisciplinary Approach in Prenatal Diagnosis of TSC With Cardiac Rhabdomyoma as the Initial Symptom.

作者信息

Qi Yiming, Ding Hongke, Huang Yanlin, Zeng Yukun, Yu Lihua, Liu Ling, Zhang Yan, Yin Aihua

机构信息

Prenatal Diagnosis Centre, Guangdong Women and Children Hospital, Guangzhou, China.

Maternal and Children Metabolic-Genetic Key Laboratory, Guangdong Women and Children Hospital, Guangzhou, China.

出版信息

Front Pediatr. 2021 Aug 27;9:628238. doi: 10.3389/fped.2021.628238. eCollection 2021.

Abstract

The long-term prognosis of a fetus with cardiac rhabdomyoma (CR) depends on the correlation with tuberous sclerosis complex (TSC). In recent years, the numerous variations of uncertain significance (VUS) of TSC genes produced by high-throughput sequencing have made counseling challenging, studies until now have tended to side-step the tricky topics. Here, we integrated detailed parental phenotype, echocardiography, neuro MRI, and genetic information to conduct a comprehensive evaluation of 61 CR fetuses. As a result, multiple CRs and cerebral lesions appeared in 90 and 80%, respectively of fetuses with pathogenic (P)/likely pathogenic (LP) TSC1/TSC2 variations. Overall, 85.7% of the live-born infants with P/LP presented with TSC-associated signs. While, 85.7% of VUS without nervous findings had good prognoses. Genetic evidence and cerebral MRI findings are the most sensitive index to assess long-term prognosis, which complement and confirm each other for a TSC diagnosis. In total, 68.9% of fetuses with CR could benefit from this multidisciplinary approach, which turned out to be potentially clinically actionable with precise clinical/genetic diagnosis or had a foreseeable outcome. Our practice provides a practical and feasible solution for perinatal management and prognostic guidance for fetuses with CR.

摘要

患有心脏横纹肌瘤(CR)的胎儿的长期预后取决于与结节性硬化症(TSC)的相关性。近年来,高通量测序产生的大量意义未明的TSC基因变异(VUS)给咨询带来了挑战,迄今为止的研究往往回避了这些棘手的话题。在此,我们整合了详细的父母表型、超声心动图、神经磁共振成像和基因信息,对61例CR胎儿进行了全面评估。结果,分别有90%和80%的携带致病性(P)/可能致病性(LP)TSC1/TSC2变异的胎儿出现多个CR和脑部病变。总体而言,85.7%的P/LP活产婴儿出现了与TSC相关的体征。而没有神经学表现的VUS中,85.7%预后良好。基因证据和脑部磁共振成像结果是评估长期预后最敏感的指标,它们相互补充并相互印证以进行TSC诊断。总的来说,68.9%的CR胎儿可从这种多学科方法中获益,这种方法通过精确的临床/基因诊断在临床上具有潜在的可操作性或具有可预见的结果。我们的实践为CR胎儿的围产期管理和预后指导提供了切实可行的解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bef/8429840/b929728bb0b9/fped-09-628238-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验